Logo
x

Search

Subscribe Now

biotheus

Biotheus Reports Collaboration Expansion with Hansoh Pharma to Develop EGFR/cMET Bispecific Antibody-Drug Conjugates

Biotheus Reports Collaboration Expansion with Hansoh Pharma to Develop EGFR/cMET Bispecific Antibody-Drug Conjugates

  • March 15, 2024
Biotheus and Bitterroot Bio Join Forces for the Development of Bispecific Proteins in Cardio-Immunology

Biotheus and Bitterroot Bio Join Forces for the Development of Bispecific Proteins in Cardio-Immunology

  • February 27, 2024
Biotheus Collaborates with BioNTech for the Development and Commercialization of PM8002 to Treat Multiple Solid Tumor Indications

Biotheus Collaborates with BioNTech for the Development and Commercialization of PM8002 to Treat Multiple Solid Tumor Indications

  • November 7, 2023
Biotheus Entered into a Research Collaboration and License Agreement with BioNTech to Discover Novel Therapies for Cancer

Biotheus Entered into a Research Collaboration and License Agreement with BioNTech to Discover Novel Therapies for Cancer

  • July 20, 2023
Biotheus Entered into a License and Collaboration Agreement with Hansoh Pharma for PM1080

Biotheus Entered into a License and Collaboration Agreement with Hansoh Pharma for PM1080

  • November 15, 2022
PharmaShots Weekly Snapshot (August 19 - 23, 2019)

PharmaShots Weekly Snapshot (August 19 - 23, 2019)

  • August 26, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.